tradingkey.logo
tradingkey.logo
Search

Curis Inc

CRIS
Add to Watchlist
0.522USD
+0.080+18.12%
Close 06/30, 16:00ETQuotes delayed by 15 min
20.35MMarket Cap
LossP/E TTM

TradingKey Stock Score of Curis Inc

Currency: USD Updated: 2026-06-30

Key Insights

Curis Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 193 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Curis Inc's Score

Industry at a Glance

Industry Ranking
193 / 387
Overall Ranking
332 / 4569
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Curis Inc Highlights

StrengthsRisks
Curis, Inc. is a biotechnology company. The Company is focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase (IRAK4). Emavusertib is undergoing testing in the Phase I/II TakeAim Lymphoma study in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase I/II TakeAim Leukemia study in patients with I/II TakeAim Leukemia study in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS). The Erivedge, is a commercialized orally administered small molecule Hedgehog signaling pathway antagonist. Its other clinical programs include Fimepinostat and CA-170. CA-170 is an oral small molecule drug candidate that targets V-domain Ig Suppressor of T-cell Activation, or VISTA, and PDL1 immune checkpoint proteins.
Growing
The company is in a growing phase, with the latest annual income totaling USD 9.44M.
Fairly Valued
The company’s latest PE is -0.91, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 9.82M shares, increasing 31.37% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 51.34K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 13.53.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
14.000
Target Price
+3067.42%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Curis Inc?

The TradingKey Stock Score provides a comprehensive assessment of Curis Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Curis Inc’s performance and outlook.

How do we generate the financial health score of Curis Inc?

To generate the financial health score of Curis Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Curis Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Curis Inc.

How do we generate the company valuation score of Curis Inc?

To generate the company valuation score of Curis Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Curis Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Curis Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Curis Inc.

How do we generate the earnings forecast score of Curis Inc?

To calculate the earnings forecast score of Curis Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Curis Inc’s future.

How do we generate the price momentum score of Curis Inc?

When generating the price momentum score for Curis Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Curis Inc’s prices. A higher score indicates a more stable short-term price trend for Curis Inc.

How do we generate the institutional confidence score of Curis Inc?

To generate the institutional confidence score of Curis Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Curis Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Curis Inc.

How do we generate the risk management score of Curis Inc?

To assess the risk management score of Curis Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Curis Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Curis Inc.